Abstract
In recent years, obesity and related medical conditions have become leading public health concerns worldwide. Policy measures to combat or prevent obesity have been instated in a number of countries, with varying degrees of success. To stress the importance of obesity as a health issue, many professional health organizations, including the American Medical Association, have defined obesity itself as a disease. While this may be somewhat controversial, the high risk of comorbid conditions in obese individuals, the significant changes from healthy physiology that are present in the obese state, and the need for further public policies to address the public health threat and economic impact of obesity in the population are strong supporting arguments to label obesity as a disease.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
Merck's Manual of the Materia Medica, First edn. New York: Merck & Co.; 1899.
Kondo T, Kishi M, Fushimi T, Ugajin S, Kaga T. Vinegar intake reduces body weight, body fat mass, and serum triglyceride levels in obese Japanese subjects. Biosci Biotechnol Biochem. 2009;73(8):1837–43.
Phelan S, Lang W, Jordan D, Wing RR. Use of artificial sweeteners and fat-modified foods in weight loss maintainers and always-normal weight individuals. Int J Obes (Lond). 2009;33(10):1183–90.
Yanovski SZ, Yanovski JA. Long-term drug treatment for obesity: a systematic and clinical review. JAMA 2014. doi: 10.1001/jama.2013.281361.
Nguyen NT, Masoomi H, Magno CP, Nguyen XM, Laugenour K, Lane J. Trends in use of bariatric surgery, 2003-2008. J Am Coll Surg. 2011;213(2):261–6.
Buchwald H, Estok R, Fahrbach K, Banel D, Jensen MD, Pories WJ, et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med. 2009;122(3):248–256 e245.
Sjostrom L, Narbro K, Sjostrom CD, Karason K, Larsson B, Wedel H, et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med. 2007;357(8):741–52.
Mechanick JI, Garber AJ, Handelsman Y, Garvey WT. American Association of Clinical Endocrinologists’ position statement on obesity and obesity medicine. Endocr Pract. 2012;18(5):642–8.
Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence of obesity in the United States, 2009-2010. NCHS Data Brief 2012(82):1-8.
Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence of obesity and trends in body mass index among US children and adolescents, 1999-2010. JAMA. 2010;307(5):483–90.
Forrester T. Epidemiologic transitions: migration and development of obesity and cardiometabolic disease in the developing world. Nestle Nutr Inst Workshop Ser. 2013;71:147–56.
Gotay CC, Katzmarzyk PT, Janssen I, Dawson MY, Aminoltejari K, Bartley NL. Updating the Canadian obesity maps: an epidemic in progress. Can J Public Health. 2012;104(1):e64–8.
Kapantais E, Tzotzas T, Ioannidis I, Mortoglou A, Bakatselos S, Kaklamanou M, et al. First national epidemiological survey on the prevalence of obesity and abdominal fat distribution in Greek adults. Ann Nutr Metab. 2006;50(4):330–8.
Miranda JJ, Herrera VM, Chirinos JA, Gomez LF, Perel P, Pichardo R, et al. Major cardiovascular risk factors in Latin America: a comparison with the United States. The Latin American Consortium of Studies in Obesity (LASO). PLoS One. 2013;8(1), e54056.
Sundborn G, Metcalf PA, Gentles D, Scragg R, Dyall L, Black P, et al. Overweight and obesity prevalence among adult Pacific peoples and Europeans in the Diabetes Heart and Health Study (DHAHS) 2002-2003, Auckland New Zealand. N Z Med J. 2010;123(1311):30–42.
World Health Organization. Obesity and Overweight Fact Sheet [http://www.who.int/mediacentre/factsheets/fs311/en/].
Lubrano C, Genovesi G, Specchia P, Costantini D, Mariani S, Petrangeli E, et al. Obesity and metabolic comorbidities: environmental diseases? Oxid Med Cell Longev. 2013;2013:640673.
Frood S, Johnston LM, Matteson CL, Finegood DT. Obesity, complexity, and the role of the health system. Curr Obes Rep. 2013;2:320–6. This review article highlights the multiplicity of factors driving trends in obesity.
Bray GA, Nielsen SJ, Popkin BM. Consumption of high-fructose corn syrup in beverages may play a role in the epidemic of obesity. Am J Clin Nutr. 2004;79(4):537–43.
Caterson ID, Hubbard V, Bray GA, Grunstein R, Hansen BC, Hong Y, et al. Prevention Conference VII: obesity, a worldwide epidemic related to heart disease and stroke: Group III: worldwide comorbidities of obesity. Circulation. 2004;110(18):e476–83.
Brody J. A label calls attention to obesity. In: The New York times. New York; 2013.
Kopelman P, Jebb SA, Butland B. Executive summary: foresight ‘tackling obesities: future choices’ project. Obes Rev. 2007;8 Suppl 1:vi–ix.
Carter S, Caron A, Richard D, Picard F. Role of leptin resistance in the development of obesity in older patients. Clin Interv Aging. 2013;8:829–44.
Muscelli E, Mari A, Casolaro A, Camastra S, Seghieri G, Gastaldelli A, et al. Separate impact of obesity and glucose tolerance on the incretin effect in normal subjects and type 2 diabetic patients. Diabetes. 2008;57(5):1340–8.
Scarpellini E, Tack J. Obesity and metabolic syndrome: an inflammatory condition. Dig Dis. 2012;30(2):148–53.
Ludvik B, Nolan JJ, Baloga J, Sacks D, Olefsky J. Effect of obesity on insulin resistance in normal subjects and patients with NIDDM. Diabetes. 1995;44(9):1121–5.
Narayan KM, Boyle JP, Thompson TJ, Gregg EW, Williamson DF. Effect of BMI on lifetime risk for diabetes in the U.S. Diabetes Care. 2007;30(6):1562–6.
Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante Jr AW. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest. 2003;112(12):1796–808.
Zorzano A, Liesa M, Palacin M. Role of mitochondrial dynamics proteins in the pathophysiology of obesity and type 2 diabetes. Int J Biochem Cell Biol. 2009;41(10):1846–54.
Sebastian D, Hernandez-Alvarez MI, Segales J, Sorianello E, Munoz JP, Sala D, et al. Mitofusin 2 (Mfn2) links mitochondrial and endoplasmic reticulum function with insulin signaling and is essential for normal glucose homeostasis. Proc Natl Acad Sci U S A. 2012;109(14):5523–8.
Ozcan U, Yilmaz E, Ozcan L, Furuhashi M, Vaillancourt E, Smith RO, et al. Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes. Science. 2006;313(5790):1137–40.
Ozcan L, Ergin AS, Lu A, Chung J, Sarkar S, Nie D, et al. Endoplasmic reticulum stress plays a central role in development of leptin resistance. Cell Metab. 2009;9(1):35–51.
Youssef WI, McCullough AJ. Steatohepatitis in obese individuals. Best Pract Res Clin Gastroenterol. 2002;16(5):733–47.
Kenchaiah S, Evans JC, Levy D, Wilson PW, Benjamin EJ, Larson MG, et al. Obesity and the risk of heart failure. N Engl J Med. 2002;347(5):305–13.
Wang TJ, Parise H, Levy D, D'Agostino Sr RB, Wolf PA, Vasan RS, et al. Obesity and the risk of new-onset atrial fibrillation. JAMA. 2004;292(20):2471–7.
Jones RL, Nzekwu MM. The effects of body mass index on lung volumes. Chest. 2006;130(3):827–33.
Hsu CY, McCulloch CE, Iribarren C, Darbinian J, Go AS. Body mass index and risk for end-stage renal disease. Ann Intern Med. 2006;144(1):21–8.
Thaler JP, Guyenet SJ, Dorfman MD, Wisse BE, Schwartz MW. Hypothalamic inflammation: marker or mechanism of obesity pathogenesis? Diabetes. 2013;62(8):2629–34.
Fitzgibbon ML, Beech BM. The role of culture in the context of school-based BMI screening. Pediatrics. 2009;124 Suppl 1:S50–62.
Riggs N, Tewari A, Stigler M, Rodrigues L, Arora M, Khubchandani J, et al. Indian students’ perspectives on obesity and school-based obesity prevention: a qualitative examination. Health Promot Pract. 2013;14(6):816–23.
Williams KJ, Taylor CA, Wolf KN, Lawson RF, Crespo R. Cultural perceptions of healthy weight in rural Appalachian youth. Rural Remote Health. 2008;8(2):932.
Drewnowski A. The cost of US foods as related to their nutritive value. Am J Clin Nutr. 2010;92(5):1181–8.
Darmon N, Drewnowski A. Does social class predict diet quality? Am J Clin Nutr. 2008;87(5):1107–17.
Christian TJ. Trade-offs between commuting time and health-related activities. J Urban Health. 2012;89(5):746–57.
Hawkes C, Lobstein T. Regulating the commercial promotion of food to children: a survey of actions worldwide. Int J Pediatr Obes. 2011;6(2):83–94.
Popkin BM, Adair LS, Ng SW. Global nutrition transition and the pandemic of obesity in developing countries. Nutr Rev. 2012;70(1):3–21.
Jalonick MC. Congress pushes back on healthier school lunches, fights to keep pizza and fries. In: The Huffington post. 2011.
Kraak VI, Story M, Wartella EA, Ginter J. Industry progress to market a healthful diet to American children and adolescents. Am J Prev Med. 2011;41(3):322–33. quiz A324.
Downey M, Still C. Survey of antiobesity legislation: are these laws working? Curr Opin Endocrinol Diabetes Obes. 2012;19(5):375–80. This article provides a comprehensive overview and critique of current public policy and legislative efforts meant to curtail obesity.
Trivedi NJ, Fields J, Mechanick CH, Klein M, Mechanick JI. Lack of correlation between antiobesity policy and obesity growth rates: review and analysis. Endocr Pract. 2012;18(5):737–44.
Wilson D. Special Report: How Washington went soft on childhood obesity. In: Reuters; 2012.
Sturm R, Powell LM, Chriqui JF, Chaloupka FJ. Soda taxes, soft drink consumption, and children's body mass index. Health Aff (Millwood). 2010;29(5):1052–8.
Van Hook J, Altman CE. Competitive food sales in schools and childhood obesity: a longitudinal study. Sociol Educ. 2012;85(1):23–39.
Tandon PS, Zhou C, Chan NL, Lozano P, Couch SC, Glanz K, et al. The impact of menu labeling on fast-food purchases for children and parents. Am J Prev Med. 2011;41(4):434–8.
Slater SJ, Nicholson L, Chriqui J, Turner L, Chaloupka F. The impact of state laws and district policies on physical education and recess practices in a nationally representative sample of US public elementary schools. Arch Pediatr Adolesc Med. 2012;166(4):311–6.
Alvaro C, Jackson LA, Kirk S, McHugh TL, Hughes J, Chircop A, et al. Moving Canadian governmental policies beyond a focus on individual lifestyle: some insights from complexity and critical theories. Health Promot Int. 2011;26(1):91–9.
Baillie-Hamilton PF. Chemical toxins: a hypothesis to explain the global obesity epidemic. J Altern Complement Med. 2002;8(2):185–92.
Decherf S, Demeneix BA. The obesogen hypothesis: a shift of focus from the periphery to the hypothalamus. J Toxicol Environ Health B Crit Rev. 2011;14(5–7):423–48.
Health Implications of Obesity. In: National Institutes of Health Consensus Statement: 11-13 February 1985.
Heshka S, Allison DB. Is obesity a disease? Int J Obes Relat Metab Disord. 2001;25(10):1401–4.
Stern JS, Thomas PR. A commentary on weighing the options: criteria for evaluating weight-management programs. Obes Res. 1995;3(6):589–90.
Obesity as a disease. The Obesity Society Council Resolution. Obesity 2008, 16(6):1151.
Martin DW: AMERICAN MEDICAL ASSOCIATION HOUSE OF DELEGATES (A-13). In: 2013.
Hoyt CL, Burnette. JL. Should obesity be a ‘disease’? In: The New York Times. New York; 2014.
Hoyt CL, Burnette JL, Auster-Gussman L. “Obesity Is a Disease”: Examining the self-regulatory impact of this public-health message. Psychol Sci 2014.
Christakis NA, Fowler JH. The spread of obesity in a large social network over 32 years. N Engl J Med. 2007;357(4):370–9.
Teixeira PJ, Mata J, Williams GC, Gorin AA, Lemieux S. Self-regulation, motivation, and psychosocial factors in weight management. J Obes. 2012;2012:582348.
Kabat G. Why labeling obesity as a disease is a big mistake. In: Forbes. 2013, July 9.
Fryhofer S. Is obesity a disease. In: The Council on Science and Publich Health: 2013; 2013.
Kramer CK, Zinman B, Retnakaran R. Are metabolically healthy overweight and obesity benign conditions?: a systematic review and meta-analysis. Ann Intern Med. 2013;159(11):758–69.
Padwal RS, Pajewski NM, Allison DB, Sharma AM. Using the Edmonton obesity staging system to predict mortality in a population-representative cohort of people with overweight and obesity. CMAJ. 2011;183(14):E1059–66.
Compliance with Ethics Guidelines
Conflict of Interest
Michael A. Via declares that he has no conflict of interest.
Jeffrey I. Mechanick has received honoraria from Abbott Nutrition for lectures and program development.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Via, M.A., Mechanick, J.I. Obesity as a Disease. Curr Obes Rep 3, 291–297 (2014). https://doi.org/10.1007/s13679-014-0108-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13679-014-0108-9